BDNF Val66Met Polymorphism Is Related to Motor System Function After Stroke

Physical Therapy

Volumn 96, Issue 4, 2016, Pages 533-539

  Kim, D Y ^a   Quinlan, E B ^b   Gramer, R ^b   Cramer, S C ^b  

^a University of Ulsan   (South Korea)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN;

CEREBROVASCULAR ACCIDENT; CONVALESCENCE; DISABILITY; FEMALE; GENETICS; GENOTYPE; HAND; HUMAN; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PHYSIOLOGY; SENSORIMOTOR CORTEX; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE REHABILITATION;

BRAIN-DERIVED NEUROTROPHIC FACTOR; DISABILITY EVALUATION; FEMALE; GENOTYPE; HAND; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECOVERY OF FUNCTION; SENSORIMOTOR CORTEX; STROKE; STROKE REHABILITATION;

EID: 84962339226     PISSN: 00319023     EISSN: 15386724     Source Type: Journal    
DOI: 10.2522/ptj.20150135     Document Type: Article

References (48)

1. Cramer SC. Repairing the human brain after stroke, II: restorative therapies. Ann Neurol. 2008; 63: 549-560
2. Zhang ZG, Chopp M. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 2009; 8: 491-500.
3. Cramer SC. Stratifying patients with stroke in trials that target brain repair. Stroke. 2010; 41: S114-S116.
4. Hosp JA, Luft AR. Cortical plasticity during motor learning and recovery after ischemic stroke. Neural Plast. 2011; 2011: 871296.
5. Dancause N, Nudo RJ. Shaping plasticity to enhance recovery after injury. Prog Brain Res. 2011; 192: 273-295.
6. Cramer SC. A window into the molecular basis of human brain plasticity. J Physiol. 2008; 586: 5601.
7. Pearson-Fuhrhop KM, Burke E, Cramer SC. The influence of genetic factors on brain plasticity and recovery after neural injury. Curr Opin Neurol. 2012; 25: 682-688.
8. Beauchaine TP. The role of biomarkers and endophenotypes in prevention and treatment of psychopathological disorders. Biomark Med. 2009; 3: 1-3.
9. Gottesman, II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160: 636-645.
10. Spence SJ, Cantor RM, Chung L, et al. Stratification based on language-related endophenotypes in autism: attempt to replicate reported linkage. Am J Med Genet B Neuropsychiatr Genet. 2006; 141B: 591-598.
11. van Nuenen BF, Weiss MM, Bloem BR, et al. Heterozygous carriers of a parkin or PINK1 mutation share a common functional endophenotype. Neurology. 2009; 72: 1041-1047.
12. Cotman CW, Berchtold NC. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002; 25: 295-301.
13. Zhao LR, Risedal A, Wojcik A, et al. Enriched environment influences brainderived neurotrophic factor levels in rat forebrain after focal stroke. Neurosci Lett. 2001; 305: 169-172.
14. Zhang Y, Pardridge WM. Blood-brain barrier targeting of BDNF improves motor function in rats with middle cerebral artery occlusion. Brain Res. 2006; 1111: 227-229.
15. Schabitz WR, Berger C, Kollmar R, et al. Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke. 2004; 35: 992-997.
16. Shimizu E, Hashimoto K, Iyo M. Ethnic difference of the BDNF 196G/A (val66met) polymorphism frequencies: the possibility to explain ethnic mental traits. Am J Med Genet B Neuropsychiatr Genet. 2004; 126B: 122-123.
17. Egan MF, Kojima M, Callicott JH, et al. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell. 2003; 112: 257-269.
18. Duan J, Wainwright MS, Comeron JM, et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. Hum Mol Genet. 2003; 12: 205-216.
19. Subramaniam AR, Pan T, Cluzel P. Environmental perturbations lift the degeneracy of the genetic code to regulate protein levels in bacteria. Proc Natl Acad Sci USA. 2013; 110: 2419-2424.
20. Kleim JA, Chan S, Pringle E, et al. BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex. Nat Neurosci. 2006; 9: 735-737.
21. Cheeran B, Talelli P, Mori F, et al. A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rtms. J Physiol. 2008; 586: 5717-5725.
22. McHughen SA, Rodriguez PF, Kleim JA, et al. BDNF val66met polymorphism influences motor system function in the human brain. Cereb Cortex. 2010; 20: 1254-1262.
23. Fritsch B, Reis J, Martinowich K, et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron. 2010; 66: 198-204.
24. Siironen J, Juvela S, Kanarek K, et al. The Met allele of the BDNF Val66Met polymorphism predicts poor outcome among survivors of aneurysmal subarachnoid hemorrhage. Stroke. 2007; 38: 2858-2860.
25. Vilkki J, Lappalainen J, Juvela S, et al. Relationship of the Met allele of the brainderived neurotrophic factor Val66Met polymorphism to memory after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2008; 63: 198-203.
26. Cramer SC, Procaccio V; GAIN Americas and GAIN International Studies Investigators. Correlation between genetic polymorphisms and stroke recovery: analysis of the GAIN Americas and GAIN International Studies. Eur J Neurol. 2012; 19: 718-724.
27. Westbroek EM, Pawlikowska L, Lawton MT, et al. Brain-derived neurotrophic factor val66met polymorphism predicts worse functional outcome after surgery in patients with unruptured brain arteriovenous malformation. Stroke. 2012; 43: 2255-2257.
28. Kim JM, Stewart R, Park MS, et al. Associations of BDNF genotype and promoter methylation with acute and long-term stroke outcomes in an East Asian cohort. PloS One. 2012; 7: e51280.
29. Dodakian L, Sharp K, See J, et al. Targeted engagement of a dorsal premotor circuit in the treatment of post-stroke paresis. NeuroRehabilitation. 2013; 33: 13-24.
30. Robot-assisted hand motor therapy for subjects with hemiparetic stroke (Robot3). ClinTrials. gov Identifier: NCT01244243. Available at: https: // clinicaltrials. gov/ct2/show/NCT01244243. Accessed June 30, 2015.
31. See J, Dodakian L, Chou C, et al. A standardized approach to the Fugl-Meyer assessment and its implications for clinical trials. Neurorehabil Neural Repair. 2013; 27: 732-741.
32. Yozbatiran N, Der-Yeghiaian L, Cramer SC. A standardized approach to performing the Action Research Arm Test. Neurorehabil Neural Repair. 2008; 22: 78-90.
33. Brott T, Adams H, Olinger C, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989; 20: 864-870.
34. Agrell B, Dehlin O. Comparison of six depression rating scales in geriatric stroke patients. Stroke. 1989; 20: 1190-1194.
35. Lincoln N, Jackson J, Adams S. Reliability and revision of the Nottingham Sensory Assessment for stroke patients. Physiotherapy. 1998; 84: 358-365.
36. Takahashi CD, Der-Yeghiaian L, Le V, et al. Robot-based hand motor therapy after stroke. Brain. 2008; 131: 425-437.
37. Mayka MA, Corcos DM, Leurgans SE, Vaillancourt DE. Three-dimensional locations and boundaries of motor and premotor cortices as defined by functional brain imaging: a meta-analysis. NeuroImage. 2006; 31: 1453-1474.
38. Mang CS, Campbell KL, Ross CJ, Boyd LA. Promoting neuroplasticity for motor rehabilitation after stroke: considering the effects of aerobic exercise and genetic variation on brain-derived neurotrophic factor. Phys Ther. 2013; 93: 1707-1716.
39. Zemke A, Heagerty P, Lee C, Cramer SC. Motor cortex organization after stroke is related to side of stroke and level of recovery. Stroke. 2003; 34: E23-E28.
40. Cramer SC, Crafton KR. Somatotopy and movement representation sites following cortical stroke. Exp Brain Res. 2006; 168: 25-32.
41. Bookheimer S, Strojwas M, Cohen M, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med. 2000; 343: 450-456.
42. Gerretsen P, Muller DJ, Tiwari A, et al. The intersection of pharmacology, imaging, and genetics in the development of personalized medicine. Dialogues Clin Neurosci. 2009; 11: 363-376.
43. Manoach DS, Agam Y. Neural markers of errors as endophenotypes in neuropsychiatric disorders. Front Hum Neurosci. 2013; 7: 350.
44. Collins JM. Functional imaging in phase I studies: decorations or decision making? J Clin Oncol. 2003; 21: 2807-2809.
45. Milot MH, Cramer SC. Biomarkers of recovery after stroke. Curr Opin Neurol. 2008; 21: 654-659.
46. Jayasekeran V, Pendleton N, Holland G, et al. Val66met in brain-derived neurotrophic factor affects stimulus-induced plasticity in the human pharyngeal motor cortex. Gastroenterology. 2011; 141: 827-836. e1-3.
47. Di Lazzaro V, Pellegrino G, Di Pino G, et al. Val66met BDNF gene polymorphism influences human motor cortex plasticity in acute stroke. Brain Stim. 2015; 8: 92-96.
48. Jeste SS, Geschwind DH. Disentangling the heterogeneity of autism spectrum disorder through genetic findings. Nat Rev Neurol. 2014; 10: 74-81.